DS-002

N/A

Report date: 2022/08/03 20:00:23

Base Information

Drug NameDS-002
Drug Alias NameDS-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNerve growth factor inhibitors
TargetsNerve growth factor
Therapy Area/IndicationsCancer PainPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesDartsbio Pharmaceuticals Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesDartsbio Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsCancer PainPain
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksN/A